共 21 条
[2]
Complications: tracking down the data on oseltamivir
[J].
BMJ-BRITISH MEDICAL JOURNAL,
2009, 339
[3]
Neuraminidase inhibitors-the story behind the Cochrane review
[J].
BMJ-BRITISH MEDICAL JOURNAL,
2009, 339
:1348-1351
[4]
Reporting conflicts of interest, financial aspects of research, and role of sponsors in funded studies
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2005, 294 (01)
:110-111
[5]
What can we learn from observational studies of oseltamivir to treat influenza in healthy adults?
[J].
BMJ-BRITISH MEDICAL JOURNAL,
2009, 339
:1352-1354
[6]
GARRATINI S, 2009, BRIT MED J, V338, pB1025
[7]
GODLEE F, 2006, BMJ-BRIT MED J, V333, DOI DOI 10.1136/BMJ.333.7567.0-F
[8]
Good publication practice for communicating company sponsored medical research: the GPP2 guidelines
[J].
BRITISH MEDICAL JOURNAL,
2009, 339
:1299-1303
[9]
Mandatory disclosure of trial results for drugs and devices - New US law will require public posting of all the main results and data on harms
[J].
BRITISH MEDICAL JOURNAL,
2008, 336 (7637)
:170-170